TJ Biopharma is a fully integrated biotech company at the forefront of pioneering cutting-edge therapies for autoimmune diseases, immuno-oncology and metabolic disorders. Through its R&D and manufacturing establishments in China, including comprehensive R&D centers in Shanghai and Beijing and a state-of-the-art GMP manufacturing facility in Hangzhou, TJ Biopharma has developed a differentiated and advanced pipeline of innovative clinical and pre-clinical assets, with its first series of advanced clinical assets now progressing toward market approval. Over the years, the Company has established a series of development and commercialization partnerships with Jumpcan, CSPC, Sanofi, and others to commercialize its pipeline products. TJ Biopharma is committed to driving excellence in drug innovation and development through a diverse and sustainable revenue model comprising global asset transactions, contract manufacturing services and future sales revenues.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Hangzhou, Cn
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tjbio.com/en
- Keywords
- Immuno-oncology, Autoimmune Diseases, Metabolic Disorders, Immunotherapy, Discovery, Clinical Development, GMP Manufacturing, Commercial Partnership.
- HQ
- Hangzhou
Tj Biopharma Questions
Tj Biopharma's website is http://www.tjbio.com/en
Tj Biopharma's LinkedIn profile is https://cn.linkedin.com/company/tjbio
Tj Biopharma has
7 employees.
View email and phone details for 7
employees at Tj Biopharma.
Tj Biopharma's industry is
Biotechnology Research
Tj Biopharma's top competitors are
Arctic Vision Ltd.,
The Investigator Taiwan,
Hengrui Pharma,
財團法人醫藥品查驗中心 (Center For Drug Evaluation, Cde),
天境生物科技(上海)有限公司,
浙江星巢网络科技有限公司,
Curocell,
Genexine, Inc.,
I-Mab Biopharma,
Qilu Pharmaceuticals.
Tj Biopharma's categories are Biotechnology Research
Tj Biopharma's founding year is 2016
